FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CHIDAMBARAM CHIDAMBARAM ALAGAPPA

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/22/2019 

3. Issuer Name and Ticker or Trading Symbol

DENTSPLY SIRONA Inc. [XRAY]

(Last)        (First)        (Middle)

13320 BALLANTYNE CORPORATE PLACE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, Chief Digital Officer /

(Street)

CHARLOTTE, NC 28277       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   4534.655   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)     (2) 11/13/2028   Common Stock   2200   $36.71   D    
Stock Option (Right to Buy)     (2) 11/13/2028   Common Stock   11600   $36.71   D    
Stock Option (Right to Buy)     (3) 3/12/2029   Common Stock   5300   $49.29   D    

Explanation of Responses:
(1)  The amount shown represents Restricted Stock Units (RSUs).
(2)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending November 13, 2021.
(3)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
CHIDAMBARAM CHIDAMBARAM ALAGAPPA
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277


SVP, Chief Digital Officer

Signatures
Dane Baumgardner, Attorney-In-Fact for Chidambaram A. Chidambaram 6/3/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more DENTSPLY SIRONA Charts.